Paul Reider - Apr 1, 2023 Form 4 Insider Report for Coherus BioSciences, Inc. (CHRS)

Role
Chief Commercial Officer
Signature
/s/ McDavid Stilwell, as Attorney-in-Fact for Paul Reider
Stock symbol
CHRS
Transactions as of
Apr 1, 2023
Transactions value $
-$16,765
Form type
4
Date filed
4/4/2023, 08:57 PM
Previous filing
Mar 28, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CHRS Common Stock Tax liability -$16.8K -2.45K -2.74% $6.84 87.1K Apr 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3.